Publication | Closed Access

The Myeloid U937 Skin Sensitization Test (U-SENS) addresses the activation of dendritic cell event in the adverse outcome pathway for skin sensitization

AllergyAutoimmune DiseaseMedicineCutaneous BiologyImmunologySkin AllergyAutoimmunityDermatologyDermatopathologyImmunotherapyDendritic Cell EventSkin SensitizationExperimental DermatologyAdverse Outcome PathwaySkin Testing